Insulet Corporation is a medical device company that specializes in the development, manufacturing, and marketing of innovative insulin delivery systems for people with diabetes. The company was founded in 2000 by John L. Brooks III and Duane DeSisto and is headquartered in Acton, Massachusetts.
Insulet is best known for its Omnipod Insulin Management System, a tubeless, wearable insulin pump that provides continuous subcutaneous insulin infusion (CSII) for individuals with type 1 and type 2 diabetes who require insulin. The Omnipod system consists of two key components:
- Omnipod Pod: This small, lightweight, and waterproof device contains an insulin reservoir, infusion set, and automated cannula insertion system. The Pod adheres directly to the user's skin and delivers insulin according to a personalized basal rate and bolus doses programmed by the user.
- Omnipod Personal Diabetes Manager (PDM): This handheld device is used to wirelessly communicate with the Pod, enabling users to program their insulin delivery, monitor insulin on board, and check their blood glucose levels. The PDM also has a built-in blood glucose meter for added convenience.
The Omnipod system offers several advantages over traditional insulin pumps, such as:
- No tubing: The absence of tubing connecting the Pod to the PDM allows for greater freedom of movement and reduced risk of snagging or tangling.
- Discreet and comfortable: The Pod's compact design makes it less noticeable and more comfortable to wear than traditional insulin pumps.
- Waterproof: The Pod is waterproof up to 25 feet for 60 minutes, allowing users to swim, shower, or engage in water-based activities without worrying about damaging their insulin pump.
Insulet is committed to innovation and continuously works on enhancing its products and services. The company is focused on expanding the capabilities of the Omnipod system, such as integrating continuous glucose monitoring (CGM) technology and developing closed-loop systems that automatically adjust insulin delivery based on real-time glucose data.
Insulet Corporation is led by President and CEO Shacey Petrovic. The company is publicly traded on the NASDAQ Stock Market under the ticker symbol "PODD." Please note that the company's organizational structure and leadership may have changed since then.
Comments